| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5697575 | Cancer Treatment Reviews | 2017 | 36 Pages |
Abstract
There is variability in treatment effect on PFS in patients with measurable and non-measurable disease, especially those with bone-only disease. Standardization of PFS determination in these patients is warranted.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Hadar Goldvaser, Domen Ribnikar, Rouhi Fazelzad, Bostjan Seruga, Arnoud J. Templeton, Alberto Ocana, Eitan Amir,